Xenotransplantation: progress toward clinical development.
Ferran
C
C
Department of Surgery, Sandoz Center for Immunobiology, Beth Israel/Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Badrichani
A Z
AZ
Cooper
J T
JT
Stroka
D M
DM
Bach
F H
FH
D000818:Animals; D000906:Antibodies / Q000276:immunology; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors; D005818:Genetic Engineering / Q000379:methods; D006084:Graft Rejection / Q000503:physiopathology / Q000517:prevention & control; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D014183:Transplantation, Heterologous / Q000276:immunology / Q000639:trends*
D000906:Antibodies; D003169:Complement Inactivator Proteins; D016207:Cytokines; D016328:NF-kappa B